Next Article in Journal
Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity
Previous Article in Journal
Prediction of Three-Month Readmission Based on Haematological Parameters in Patients with Severe COPD Exacerbation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 89
Issue 5
10.5603/ARM.a2021.0103
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Progressive Fibrosis in Interstitial Lung Diseases—Proposed Definition and Management

by
Magdalena Maria Martusewicz-Boros
1,* and
Wojciech Jerzy Piotrowski
2
1
3rd Lung Diseases and Oncology Department, National Tuberculosis and Lung Diseases Reasearch Institute in Warsaw, Warsaw, Poland
2
Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2021, 89(5), 505-510; https://doi.org/10.5603/ARM.a2021.0103
Submission received: 14 July 2021 / Revised: 25 August 2021 / Accepted: 25 August 2021 / Published: 28 October 2021

Abstract

Interstitial lung diseases may have an unpredictably progressive course, which is manifested as progression of pulmonary fibrosis, causing an increasing impairment of lung function affecting a poor prognosis. The possibility of an effective antifibrotic treatment is a chance for patients to slow down the progression of the disease, perhaps even extend their life. For this reason, standardization of the definition as well as identification criteria for progressive fibrosis interstitial lung disease is a method for optimizing the management in this group of patients.
Keywords: interstitial lung disease; progressive fibrosis; antifibrotic treatment interstitial lung disease; progressive fibrosis; antifibrotic treatment

Share and Cite

MDPI and ACS Style

Martusewicz-Boros, M.M.; Piotrowski, W.J. Progressive Fibrosis in Interstitial Lung Diseases—Proposed Definition and Management. Adv. Respir. Med. 2021, 89, 505-510. https://doi.org/10.5603/ARM.a2021.0103

AMA Style

Martusewicz-Boros MM, Piotrowski WJ. Progressive Fibrosis in Interstitial Lung Diseases—Proposed Definition and Management. Advances in Respiratory Medicine. 2021; 89(5):505-510. https://doi.org/10.5603/ARM.a2021.0103

Chicago/Turabian Style

Martusewicz-Boros, Magdalena Maria, and Wojciech Jerzy Piotrowski. 2021. "Progressive Fibrosis in Interstitial Lung Diseases—Proposed Definition and Management" Advances in Respiratory Medicine 89, no. 5: 505-510. https://doi.org/10.5603/ARM.a2021.0103

APA Style

Martusewicz-Boros, M. M., & Piotrowski, W. J. (2021). Progressive Fibrosis in Interstitial Lung Diseases—Proposed Definition and Management. Advances in Respiratory Medicine, 89(5), 505-510. https://doi.org/10.5603/ARM.a2021.0103

Article Metrics

Back to TopTop